DTL
DFTX

Dynamic Technology Lab’s Definium Therapeutics DFTX Stock Holding History

Dynamic Technology Lab’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$206K Sell
10,880
-12,084
-53% -$205K 0.03% 734
2025
Q4 		$308K Buy
22,964
+12,612
+122% +$156K 0.07% 472
2025
Q3 		$122K Sell
10,352
-4,271
-29% -$39.8K 0.02% 717
2025
Q2 		$95K Buy
+14,623
New +$96.2K 0.01% 852

Other funds holding DFTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dynamic Technology Lab's DFTX Position: Q1 2026 in Review

Dynamic Technology Lab reduced its Definium Therapeutics (DFTX) stake by 53% in Q1 2026, selling an estimated $205K and leaving 10,880 shares worth $206K. The position accounts for 0.03% of the portfolio, ranked #734.

Dynamic Technology Lab first reported a position in DFTX in Q2 2025 and has held it in 4 quarters since. The position peaked at $308K in Q4 2025. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Dynamic Technology Lab held 10,880 shares of Definium Therapeutics worth $206K as of Q1 2026.
  • Dynamic Technology Lab sold 12,084 Definium Therapeutics shares in Q1 2026, an estimated $205K.
  • Definium Therapeutics made up 0.03% of Dynamic Technology Lab's portfolio in Q1 2026, its #734 holding.
  • Dynamic Technology Lab first reported a position in Definium Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Dynamic Technology Lab's Definium Therapeutics position peaked at $308K in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.